Oikonomidou PR - Search Results

1

Polycythemia is associated with bone loss and reduced osteoblast activity in mice.

Oikonomidou PR, Casu C, Yang Z, Crielaard B, Shim JH, Rivella S, Vogiatzi MG. Oikonomidou PR, et al. Osteoporos Int. 2016 Apr;27(4):1559-1568. doi: 10.1007/s00198-015-3412-7. Epub 2015 Dec 9. Osteoporos Int. 2016. PMID: 26650379 Free PMC article.

2

Minihepcidin peptides as disease modifiers in mice affected by β-thalassemia and polycythemia vera.

Casu C, Oikonomidou PR, Chen H, Nandi V, Ginzburg Y, Prasad P, Fleming RE, Shah YM, Valore EV, Nemeth E, Ganz T, MacDonald B, Rivella S. Casu C, et al. Among authors: oikonomidou pr. Blood. 2016 Jul 14;128(2):265-76. doi: 10.1182/blood-2015-10-676742. Epub 2016 May 6. Blood. 2016. PMID: 27154187 Free PMC article.

3

What can we learn from ineffective erythropoiesis in thalassemia?

Oikonomidou PR, Rivella S. Oikonomidou PR, et al. Blood Rev. 2018 Mar;32(2):130-143. doi: 10.1016/j.blre.2017.10.001. Epub 2017 Oct 3. Blood Rev. 2018. PMID: 29054350 Free PMC article. Review.

4

New strategies to target iron metabolism for the treatment of beta thalassemia.

Oikonomidou PR, Casu C, Rivella S. Oikonomidou PR, et al. Ann N Y Acad Sci. 2016 Mar;1368(1):162-8. doi: 10.1111/nyas.13018. Epub 2016 Feb 25. Ann N Y Acad Sci. 2016. PMID: 26919168 Free PMC article. Review.

5

Combination of Tmprss6- ASO and the iron chelator deferiprone improves erythropoiesis and reduces iron overload in a mouse model of beta-thalassemia intermedia.

Casu C, Aghajan M, Oikonomidou PR, Guo S, Monia BP, Rivella S. Casu C, et al. Among authors: oikonomidou pr. Haematologica. 2016 Jan;101(1):e8-e11. doi: 10.3324/haematol.2015.133348. Epub 2015 Sep 24. Haematologica. 2016. PMID: 26405152 Free PMC article. No abstract available.

6

Lack of Gdf11 does not improve anemia or prevent the activity of RAP-536 in a mouse model of β-thalassemia.

Guerra A, Oikonomidou PR, Sinha S, Zhang J, Lo Presti V, Hamilton CR, Breda L, Casu C, La P, Martins AC, Sendamarai AK, Fleming M, Rivella S. Guerra A, et al. Among authors: oikonomidou pr. Blood. 2019 Aug 8;134(6):568-572. doi: 10.1182/blood.2019001057. Epub 2019 May 31. Blood. 2019. PMID: 31151988 Free PMC article.

7

Short-term administration of JAK2 inhibitors reduces splenomegaly in mouse models of β-thalassemia intermedia and major.

Casu C, Presti VL, Oikonomidou PR, Melchiori L, Abdulmalik O, Ramos P, Rivella S. Casu C, et al. Among authors: oikonomidou pr. Haematologica. 2018 Feb;103(2):e46-e49. doi: 10.3324/haematol.2017.181511. Epub 2017 Nov 2. Haematologica. 2018. PMID: 29097498 Free PMC article. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

7 results

Search Page

Filters